AGIG ABUNDIA GLOBAL IMPACT GROUP, INC. Insider Trading

Edward Oliver Gillespie, then-CEO of AGIG, bought 11,000 shares at $1.18 on 2026-06-12; stock now at $1.14, down 78.5% from 52-week high.

Edward Oliver Gillespie, who was CEO at the time, purchased 11,000 shares at $1.18, expanding his holdings to 202,248 shares (+5.8% increase). The stock is currently trading at $1.14, representing a -78.5% decline from the 52-week high of $5.31. His prior trades at AGIG show a mixed pattern: of 5 prior purchases, only one had a measurable 90-day outcome (a -21.7% return from the 2025-12-23 buy), indicating poor timing on that tracked transaction. The company's fundamentals reflect significant operational stress, with annual revenue declining 26.7% year-over-year, a latest-quarter revenue of $133.0K, and a full-year net loss of $-5.2M. The timing of this accumulation during a period of sustained stock weakness (-36.0% over 90 days, despite +3.6% over 30 days) against deteriorating financial metrics warrants investor scrutiny into the rationale and circumstances of the purchase.

Then-CEO Gillespie Oliver buys 14,990 shares of AGIG at $1.15; stock down 78.5% from 52-week high amid unprofitable operations.

Gillespie Edward Oliver, who was CEO at the time, purchased 14,990 shares of ABUNDIA GLOBAL IMPACT GROUP, INC. at $1.15 on 2026-05-18, increasing his holdings by 8.5% to 191.2K shares. The purchase occurs while the stock is trading at $1.14, representing -78.5% from its 52-week high of $5.31 and follows a 90-day decline of -74.7%. Fundamentally, the company reported a net loss of $-5.2M in its most recent fiscal year, with annual revenue down 26.7%, though revenue in the latest quarter was $133.0K. His prior three purchases at AGIG showed pattern inconsistency: 30-day returns ranged from +50.8% to +96.4%, but all three turned negative by the 90-day mark, with a worst case of -23.0%. A cluster of 2 other insiders also bought within 14 days. The absence of well-timed 90-day outcomes across his prior AGIG transactions, combined with the company's loss-making state and sharp revenue decline, creates a mixed signal: the timing of entry into a deeply depressed stock occurs alongside a track record of reversals at this ticker and ongoing operational deterioration.

Director Bailey Robert J. bought 10,000 shares at $1.20 as 2 other insiders also purchased within 14 days at AGIG.

Director Bailey Robert J. purchased 10,000 shares at $1.20 on 2026-05-12, increasing his holdings from 95,875 shares to 105,875 shares. This transaction occurred as part of a cluster pattern, with 2 other insiders also buying within the past 14 days. The purchases occurred when the stock was trading at $1.17 (current price), which represents -78.0% from the 52-week high of $5.31 over the past 52 weeks. The company reported revenue of $132,965.00 in the latest quarter and net income of $-5,229,104.00, with annual revenue declining -26.7% year-over-year and a market cap of $51,153,568.83. The simultaneous buying activity by multiple insiders during a period of significant stock price decline and ongoing operating losses warrants investor attention to understand the underlying motivations.

Director Longo buys 10.0K shares of AGIG at $1.20; stock down 78.0% from high, company unprofitable with -$5.2M net income.

Peter F. Longo, a director of Abundia Global Impact Group, acquired 10,000 shares at $1.20 on 2026-05-12, expanding his position to 108.9K shares. The transaction occurred against a backdrop of significant distress: the stock trades at $1.17, down 78.0% from its 52-week high of $5.31, and the company reported a net loss of $5.2M on quarterly revenue of only $133.0K with annual revenue declining 26.7% year-over-year. While the 30-day price action shows a +4.5% recovery, the 90-day trend is severely negative at -61.1%, and the company remains unprofitable at a $51.2M market cap. The purchase at a depressed valuation near a multi-year low could reflect either conviction in a turnaround or compliance with pre-existing obligations; the severity of operational decline and losses warrant scrutiny of whether this signal is credible.

CEO Gillespie Edward Oliver buys 31.2K shares for $37.0K; stock down -61.1% in 90 days amid -26.7% revenue decline.

Gillespie Edward Oliver, CEO, purchased 31,220 shares totaling $36,981.70 across three transactions, bringing post-transaction holdings to 176,258 shares. This buy occurs while AGIG's stock trades at $1.17, approximately 78% below the 52-week high of $5.31, and the company reported quarterly revenue of $132,965.00 against a net loss of $-5,229,104.00. The company faces structural headwinds with annual revenue declining -26.7% year-over-year. His prior buy track record shows conflicting outcomes across timeframes: at the 30-day mark, an average return of +72.6%, yet at the 90-day mark, an average return of -16.9% with a 0.00% win rate, indicating near-term recoveries that fail to sustain over longer horizons.

CEO Oliver buys 12,500 shares ($23.9K) at $1.92 while AGIG faces -29.4% revenue decline and $-7.0M net loss

CEO Edward Oliver Oliver purchased 12,500 shares on 2025-12-23, increasing his holdings by 32.5% to 50,961 shares post-transaction. The purchase occurred at $1.92 per share, just 12 trading days after the company's listing, during a period when AGIG's fundamentals show acute deterioration: annual revenue contracted -29.4% against the prior year, with latest quarterly revenue at $200,000.00 against a full-year net loss of $-7,031,914.00. The CEO's equity commitment signals material risk absorption—Oliver is doubling down on a highly unprofitable operation in its early public-market phase, at a moment when operational headwinds are evident in the consolidated results.

Director Henninger buys 9,500 shares at $1.74; first position in AGIG (12 days post-IPO).

Director Matthew T. Henninger purchased 9,500 shares at $1.74 on 2025-12-19, establishing an initial position in the company just 12 trading days after its listing. The company is reporting severe financial distress: net income of $-7.0M, quarterly revenue of only $200.0K, and annual revenue contraction of -29.4%, with the company unprofitable over its most recent full fiscal year. The director's entry at $1.74 represents a purchase 14% below the current trading price of $2.03, though given the recency of listing, standard valuation context is not yet available. This purchase pattern—a director accumulating a new position in a deeply unprofitable, recently listed microcap—should prompt scrutiny of the transaction rationale and the company's financial trajectory.

CEO Gillespie bought 38,461 shares in AGIG across 2 transactions for $71,260.65 (avg $1.85) on 12/19 and 12/22

CEO Edward Oliver Gillespie made two consecutive purchases of AGIG shares on December 19 and December 22, acquiring 38,461 shares totaling $71,260.65 at a blended average price of $1.85. The company is in early-stage public trading (12 trading days post-listing), recently unprofitable with full-year net income of $-7,031,914.00, and faces significant headwinds with annual revenue growth of -29.4% and latest quarterly revenue of only $200,000.00. The current stock price of $2.03 reflects a modest premium to the average transaction price, yet the absence of meaningful 52-week history or a meaningful operating profit profile makes this a speculative position. An investor should monitor whether this acquisition reflects genuine business confidence or opportunistic accumulation during a volatile IPO phase in a loss-making entity.

Bower Family Holdings (10% owner) acquires 3,066,580 shares, raising stake to 5,246,760 shares (+140.7% increase).

Bower Family Holdings, a 10% shareholder in Houston American Energy, executed a substantial purchase of 3,066,580 shares on 2025-07-01, nearly tripling its stake from 2,180,180 to 5,246,760 shares. This aggressive accumulation occurs while the company faces material headwinds: annual revenue has declined 29.4%, net income sits at negative $1,032,483.00 over the latest period, and the stock is down 60.2% from its 52-week high of $23.70 despite rallying +96.2% over the past 30 days. The transaction appears to reflect a significant capital commitment during a period of operational stress, warranting examination of whether this purchase reflects conviction about turnaround prospects or positions the holder for greater influence in a distressed situation.